The Motley Fool

Should you worry when management sell shares?

There is only one reason that management buy shares – they think it’s a good time to buy. However, I’ve seen a myriad of reasons for management selling: to cover a tax bill, divorce and so on.

Sadly, for one reason or another, share prices often seem to fall after management sell shares. Kogan.Com Ltd (ASX: KGN) and Medical Developments International Ltd (ASX: MVP) are two recent examples.

So, some shareholders of Citadel Group Ltd (ASX: CGL) may be feeling a little nervous after the company announced that two founders, Dr Jakeman and Mr McConnell will be selling around 10% of their shareholdings to institutional investors to provide liquidity.

Both of the sellers received the Citadel Chairman’s approval prior to the trade and will still hold around 27% of the company’s shares between them and remain the largest shareholders by some margin.

The selling founders said: that they remain strongly committed to the business and its continuing pivot to software, the sell down was underwritten and conducted in an orderly manner, there is no intention to sell further shares in FY19 and any further sell downs would be done in an orderly off-market manner.

The Citadel share price has been a strong performer over the past year, rising by nearly 40%. I can understand why the founders chose this point in time to sell.

Foolish takeaway

If I were a Citadel shareholder I wouldn’t be overly worried. They still own a significant portion of the business, Citadel has a very promising future and even at this elevated price I think it looks good value trading at 22x FY19’s estimated earnings.

Japanese Billionaire’s Prediction Will Give You Goosebumps

When a veritable investing and entrepreneurial genius speaks, it pays to listen.

In fact, he's now preparing a $100B "war chest" to invest entirely in this "terrifying" new technology, which could spell huge profits for investors.

Click here to learn about this technology and how you can profit!

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Citadel Group Ltd. The Motley Fool Australia has recommended ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

One ASX Stock For An Estimated $US22 Billion Marijuana Market

A little-known ASX company just unlocked what some experts think could be the key to profiting off the coming marijuana boom.

And make no mistake – it is coming. To the tune of an estimated $US22 billion.

Cannabis legalisation is sweeping over North America, and full legalisation arrived in Canada in October 2018.

Here’s the best part: we think there’s one ASX stock that’s uniquely positioned to profit immensely from this explosive new industry… taking savvy investors along for what could be one heck of a ride.

AND, this is the first time The Motley Fool Australia has EVER put a BUY recommendation on a marijuana stock.

Simply click below to learn more on how you can profit from the coming cannabis boom.

Click here to find out more